Avidity Biosciences
RNA Micro CapHealthcare · Biotechnology
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Avidity Biosciences Stock at a Glance
Avidity Biosciences (RNA) is currently trading at 11,46 € with a market capitalization of 178 M €. The 52-week range spans from 10,19 € to 14,31 €; the current price is 19.9% below the yearly high. Year-over-year revenue growth stands at -71.1%.
💰 Dividendo
Avidity Biosciences currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Raccomandazioni degli Analisti
1 analysts rate Avidity Biosciences (RNA) on consensus: None. The average price target is 21,33 €, implying +86.15% from the current price. Analyst price targets range from 21,33 € to 21,33 €.
Tesi di Investimento: Punti di Forza e Debolezze
Nessun punto di forza rilevante nei dati attuali.
- –Revenue shrinking (-71.1% YoY)
- –Currently unprofitable
- –Negative free cash flow
Panoramica Tecnica
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Dati di Trading
Azioni Correlate nello Stesso Settore
Where can I buy Avidity Biosciences?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
